Bosh sahifaDMYD-B • STO
add
Diamyd Medical AB
Yopilish kursi
11,00 kr
Kunlik diapazon
10,72 kr - 11,04 kr
Yillik diapazon
7,50 kr - 19,50 kr
Bozor kapitalizatsiyasi
1,46 mlrd SEK
Oʻrtacha hajm
368,27 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | may, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 47,17 mln | 17,45% |
Sof foyda | -43,88 mln | -9,50% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | — | — |
EBITDA | -46,46 mln | -17,32% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | may, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 319,26 mln | 96,61% |
Jami aktivlari | 400,07 mln | 61,19% |
Jami passivlari | 75,40 mln | 42,93% |
Umumiy kapital | 324,67 mln | — |
Tarqatilgan aksiyalar | 137,50 mln | — |
Narxi/balansdagi bahosi | 4,66 | — |
Aktivlardan daromad | -41,41% | — |
Kapitaldan daromad | -55,16% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | may, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -43,88 mln | -9,50% |
Operatsiyalardan naqd pul | -43,50 mln | -18,29% |
Sarmoyadan naqd pul | -4,25 mln | 89,37% |
Moliyadan naqd pul | 258,96 mln | 321,52% |
Naqd pulning sof oʻzgarishi | 215,51 mln | 1 626,72% |
Boʻsh pul | -31,45 mln | -36,16% |
Haqida
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Tashkil etilgan
1984
Sayt
Xodimlar soni
30
